Johnson & Johnson, US4781601046

Johnson & Johnson stock heads into the open after a 0.19 percent slip

Published on 09/22/2026 at 08:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 21, 2026, Johnson & Johnson stock finished at USD 269.47 after 4,485,369 shares traded, while the Dow Jones Industrial Average gained 0.71 percent.

Modern hospital operating room with robotic surgical arms positioned above a draped patient, surgeons in blue sterile gowns monitoring vital-sign and anatomy screens, bright overhead surgical lighting, stainless steel instrument trays in the foreground
Johnson und US4781601046 zeigen modernen Krankenhaus OP mit Robotik Chirurgie und medizinischen Bildschirmen, Illustration mit AI erstellt.

Johnson & Johnson stock closed at USD 269.47 on the NYSE on September 21, 2026, down 0.19 percent. The Dow Jones Industrial Average gained 0.71 percent to 52,048.83, leaving Johnson & Johnson 0.90 percentage points behind its reference index. As GuruFocus reported on September 21, 2026, Johnson & Johnson announced positive topline Phase 3 Caplyta results for manic episodes in bipolar I disorder.

September 21, 2026 in numbers

Johnson & Johnson Inc. (ISIN US4781601046, NYSE: JNJ) traded at USD 269.47 at the September 21, 2026 close, according to Zacks data updated at 4:00 p.m. ET. The session change was minus 0.52 dollars, or minus 0.19 percent, on volume of 4,485,369 shares.

The session close lagged the Dow Jones Industrial Average, which added 366.19 points, or 0.71 percent, to 52,048.83 on September 21, 2026. Johnson & Johnson therefore underperformed the index by 0.90 percentage points.

Today before the open

Johnson & Johnson enters the September 22, 2026 session with the September 21 clinical update as the latest company-specific item. The broader market backdrop included a 0.71 percent gain in the Dow Jones Industrial Average on September 21, 2026.

Disclaimer...

en | US4781601046 | JOHNSON & JOHNSON | boerse | 70151527 | bgmi